No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.

Xiaoqiang Xiang,Juha Vakkilainen,Janne T. Backman,Pertti J. Neuvonen,Mikko Niemi

No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.

2011

Xiaoqiang Xiang
Juha Vakkilainen
Janne T. Backman
Pertti J. Neuvonen
Mikko Niemi

Purpose To investigate possible effects of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid (UDCA) and its metabolites in healthy volunteers.

Keywords:

Anesthesia
SLCO1B1
Pharmacogenetics
Medicine
Pharmacology
Ursodeoxycholic acid
Pharmacokinetics
Polymorphism (computer science)
pharmacology toxicology
Diabetes mellitus
healthy volunteers

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations